Hypercholesterolemia in Youth: Opportunities and Obstacles to Prevent Premature Atherosclerotic Cardiovascular Disease

Treatment of hypercholesterolemia in youth is predicated on the knowledge that we can identify those youth with this atherosclerotic risk factor most likely to develop premature cardiovascular disease. Unfortunately, this is not the case. Before we can adequately address appropriate lipid-lowering t...

Full description

Saved in:
Bibliographic Details
Published in:Current atherosclerosis reports 2010, Vol.12 (1), p.20-28
Main Authors: McNeal, Catherine J., Dajani, Tala, Wilson, Don, Cassidy-Bushrow, Andrea E., Dickerson, Justin B., Ory, Marcia
Format: Article
Language:English
Subjects:
Age Factors
Angiology
Anticholesteremic Agents - therapeutic use
Atherosclerosis - epidemiology
Atherosclerosis - etiology
Atherosclerosis - prevention & control
Cardiology
Child
Cholesterol - blood
Humans
Hypercholesterolemia - complications
Hypercholesterolemia - drug therapy
Hypercholesterolemia - epidemiology
Mass Screening
Medicine
Medicine & Public Health
Prevalence
Risk Factors
Time Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Treatment of hypercholesterolemia in youth is predicated on the knowledge that we can identify those youth with this atherosclerotic risk factor most likely to develop premature cardiovascular disease. Unfortunately, this is not the case. Before we can adequately address appropriate lipid-lowering therapies in this special population, we must address and resolve current barriers related to screening and diagnosis. In this article, we describe some of the opportunities and obstacles that clinicians and policy makers confront when applying the current pediatric guidelines focused on screening and treating hypercholesterolemia in the pediatric population.
ISSN:1523-3804
1534-6242
DOI:10.1007/s11883-009-0072-0